1. Home
  2. RVMD vs VMI Comparison

RVMD vs VMI Comparison

Compare RVMD & VMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • VMI
  • Stock Information
  • Founded
  • RVMD 2014
  • VMI 1946
  • Country
  • RVMD United States
  • VMI United States
  • Employees
  • RVMD N/A
  • VMI N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • VMI Metal Fabrications
  • Sector
  • RVMD Health Care
  • VMI Industrials
  • Exchange
  • RVMD Nasdaq
  • VMI Nasdaq
  • Market Cap
  • RVMD 7.4B
  • VMI 6.5B
  • IPO Year
  • RVMD 2020
  • VMI N/A
  • Fundamental
  • Price
  • RVMD $39.66
  • VMI $318.41
  • Analyst Decision
  • RVMD Strong Buy
  • VMI Buy
  • Analyst Count
  • RVMD 12
  • VMI 3
  • Target Price
  • RVMD $68.67
  • VMI $362.50
  • AVG Volume (30 Days)
  • RVMD 1.7M
  • VMI 150.9K
  • Earning Date
  • RVMD 08-06-2025
  • VMI 07-23-2025
  • Dividend Yield
  • RVMD N/A
  • VMI 0.85%
  • EPS Growth
  • RVMD N/A
  • VMI 129.00
  • EPS
  • RVMD N/A
  • VMI 17.19
  • Revenue
  • RVMD N/A
  • VMI $4,066,520,000.00
  • Revenue This Year
  • RVMD N/A
  • VMI $1.10
  • Revenue Next Year
  • RVMD $241.39
  • VMI $4.93
  • P/E Ratio
  • RVMD N/A
  • VMI $18.66
  • Revenue Growth
  • RVMD N/A
  • VMI N/A
  • 52 Week Low
  • RVMD $29.17
  • VMI $250.07
  • 52 Week High
  • RVMD $62.40
  • VMI $379.22
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 49.08
  • VMI 50.11
  • Support Level
  • RVMD $38.57
  • VMI $318.02
  • Resistance Level
  • RVMD $42.40
  • VMI $330.03
  • Average True Range (ATR)
  • RVMD 1.38
  • VMI 5.71
  • MACD
  • RVMD -0.16
  • VMI -1.09
  • Stochastic Oscillator
  • RVMD 28.46
  • VMI 41.99

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

Share on Social Networks: